
Keywords: Urticaria; Guidelines; Antihistamines; Omalizumab; Cyclosporine; anti-H1; H1 antihistamines; CSU; Chronic spontaneous urticaria; DLQI; Dermatology Life Quality Index; EAACI; European Academy of Allergy and Clinical Immunology; UAS; Urticaria Activity Scor